Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

Cited by (1,003)

Items 101–200 of 1,003

  1. Myocardial infarction accelerates breast cancer via innate immune reprogramming
    Graeme J. Koelwyn, Alexandra A. C. Newman, Milessa Silva Afonso, Coen V Solingen, Emma M. Corr, Emily J. Brown, Kathleen B. Albers, Naoko Yamaguchi, Deven Narke, Martin Schlegel et al. · 2020 · Nature Medicine
  2. Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer
    Xuguang Yang, Yun Lu, Junjie Hang, Junfeng Zhang, Tiening Zhang, Yan‐Miao Huo, Jun Liu, Songtao Lai, Dawei Luo, Liwei Wang et al. · 2020 · Cancer Immunology Research
  3. Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
    Yi Bao, Jianning Zhai, Huarong Chen, Chi Chun Wong, Cong Liang, Yanqiang Ding, Dan Huang, Hongyan Gou, Danyu Chen, Yasi Pan et al. · 2023 · Gut
  4. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
    Anne Tuomisto, Markus J. Mäkinen, Juha P. Väyrynen · 2019 · World Journal of Gastroenterology
  5. Emerging role of tumor cell plasticity in modifying therapeutic response
    Siyuan Qin, Jingwen Jiang, Yi Lü, Edouard Collins Nice, Canhua Huang, Jian Zhang, Weifeng He · 2020 · Signal Transduction and Targeted Therapy
  6. NK cells and ILCs in tumor immunotherapy
    Simona Sivori, Daniela Pende, Linda Quatrini, Gabriella Pietra, Mariella Della Chiesa, Paola Vacca, Nicola Tumino, Francesca Moretta, Maria Cristina Mingari, Franco Locatelli et al. · 2020 · Molecular Aspects of Medicine
  7. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
    Claire Conche, Fabian Finkelmeier, Marina Hadzi Pesic, Adele M. Nicolas, Tim W. Böttger, Kilian B. Kennel, Dominic Denk, Fatih Ceteci, Kathleen Mohs, Esther Engel et al. · 2023 · Gut
  8. Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
    Lifeng Li, Liping Wang, Jieyao Li, Zhirui Fan, Yang Li, Zhen Zhang, Chaoqi Zhang, Dongli Yue, Guohui Qin, Tengfei Zhang et al. · 2018 · Cancer Research
  9. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
    Xinyu Tian, Han Shen, Zhiyang Li, Tingting Wang, Shengjun Wang · 2019 · Journal of Hematology & Oncology
  10. Combating Implant Infections: Shifting Focus from Bacteria to Host
    Saber Amin Yavari, Suzanne M. Castenmiller, Jos A. G. van Strijp, Michiel Croes · 2020 · Advanced Materials
  11. Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression
    Sachiko Taniguchi, Ajit Elhance, Avery Van Duzer, Sushil Kumar, Justin J. Leitenberger, Naoki Oshimori · 2020 · Science
  12. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
    Robin Parihar, Charlotte Helena Rivas, Mai Huynh, Bilal A. Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen M Gottschalk, Cliona M. Rooney · 2019 · Cancer Immunology Research
  13. Pre-metastatic niche: formation, characteristics and therapeutic implication
    Yuhang Wang, Jiachi Jia, Fuqi Wang, Yingshuai Fang, Yabing Yang, Quanbo Zhou, Weitang Yuan, Xiaoming Gu, Junhong Hu, Shuaixi Yang · 2024 · Signal Transduction and Targeted Therapy
  14. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
    Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi et al. · 2018 · Journal of Clinical Investigation
  15. Aging and cancer: The role of macrophages and neutrophils
    Jackaman, Connie, Tomay, Federica, Duong, Lelinh, Abdol Razak, Norbaini Bintu, Pixley, Fiona J., Metharom, Pat, Nelson, Delia J. · 2017 · Ageing Research Reviews
  16. Neutrophils in COVID-19
    Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Kevin E. Bassler, Joachim Ludwig Schultze, Anna C. Aschenbrenner · 2021 · Frontiers in Immunology
  17. CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
    Timothy Chao, Emma Elizabeth Furth, Robert H. Vonderheide · 2016 · Cancer Immunology Research
  18. Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
    Carlos Rodrigo Gil del Alcazar, Sung Jin Huh, Muhammad B. Ekram, Anne C. Trinh, Lin L. Liu, Francisco Ferro de Beça, Xiaoyuan Zi, Minsuk Kwak, Helga Bergholtz, Ying Su et al. · 2017 · Cancer Discovery
  19. Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
    Defne Bayık, Yadi Zhou, Chihyun Park, Changjin Hong, Daniel J. Vail, Daniel J. Silver, Adam J. Lauko, Gustavo A. Roversi, Dionysios Christos Watson, Alice Lo et al. · 2020 · Cancer Discovery
  20. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
    Sunil Kumar Singhal, Jason E. Stadanlick, Michael J. Annunziata, Abhishek S. Rao, Pratik Sanjivkumar Bhojnagarwala, Shaun O’Brien, Edmund K. Moon, Edward Cantu, Gwenn A. Danet-Desnoyers, Hyun-Jeong Ra et al. · 2019 · Science Translational Medicine
  21. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
    Arsen Osipov, May Tun Saung, Lei Zheng, Adrian Gerard Murphy · 2019 · Journal for ImmunoTherapy of Cancer
  22. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
    Lillian Sun, Paúl E. Clavijo, Yvette L. Robbins, Priya Patel, Jay Friedman, Sarah Greene, Rita Das, Chris Silvin, Carter Van Waes, Lucas A. Horn et al. · 2019 · JCI Insight
  23. Perivascular Inflammation in Pulmonary Arterial Hypertension
    Yijie Hu, Leon Chi, Wolfgang Michael Kuebler, Neil M. Goldenberg · 2020 · Cells
  24. Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis
    Brian E. Hsu, Sébastien Tabariès, Radia Marie Johnson, Sylvia Andrzejewski, Julien Senécal, Camille Lehuédé, Matthew G. Annis, Eric H. Ma, Sandra Völs, LeeAnn Ramsay et al. · 2019 · Cell Reports
  25. The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
    Valeria Governa, Emanuele Trella, Valentina Mele, Luigi Tornillo, Francesca Amicarella, Eleonora Cremonesi, Manuele Giuseppe Muraro, Hui Xu, Raoul Andre Droeser, Silvio Däster et al. · 2017 · Clinical Cancer Research
  26. Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
    Ajaz Ahmad Bhat, Sabah Nisar, Mayank Kumar Singh, Bazella Ashraf, Tariq Masoodi, Chandra Prakash Prasad, Atul Sharma, Selma Maacha, Thasni Karedath, Sheema Hashem et al. · 2022 · 癌症:英文版
  27. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
    Hailong Tian, Jiangjun Cao, Bowen Li, Edouard Collins Nice, Haijiao Mao, Yi Zhang, Canhua Huang · 2023 · Bone Research
  28. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
    Gang Xu, Furong Qi, Hanjie Li, Qianting Yang, Haiyan Wang, Xin Wang, Xiaoju Liu, Juanjuan Zhao, Xuejiao Liao, Yang Liu et al. · 2020 · Cell Discovery
  29. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
    Shuyan He, Lu Zheng, Chunjian Qi · 2025 · Molecular Cancer
  30. Targeting tumor microenvironment in ovarian cancer: Premise and promise
    Yuting Jiang, Chengdi Wang, Shengtao Zhou · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  31. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
    Sara Trabanelli, Mathieu F. Chevalier, Amaia Martínez-Usatorre, Alejandra Gomez‐Cadena, Bérengère Salomé, Mariangela Lecciso, Valentina Salvestrini, Grégory Verdeil, Julien Racle, Cristina Papayannidis et al. · 2017 · Nature Communications
  32. Prostate carcinogenesis: inflammatory storms
    Johann Sebastian De Bono, Christina W. Guo, Bora Gürel, Angelo Michael De Marzo, Karen Sandell Sfanos, Ram Shankar Mani, Jesús Gil, Charles G. Drake, Andrea Alimonti · 2020 · Nature reviews. Cancer
  33. Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
    Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, Marcus Otho Butler, Mary Lenora Disis, Jérôme Galon, Leif Håkansson, Brent Allen Hanks, Vaios Karanikas, Samir N. Khleif et al. · 2017 · Journal for ImmunoTherapy of Cancer
  34. Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
    Tobias Baumann, Andreas Dunkel, Christian Schmid, Sabine Schmitt, Michael Hiltensperger, Kerstin Lohr, Vibor Laketa, Sainitin Donakonda, Uwe Ahting, Bettina Lorenz‐Depiereux et al. · 2020 · Nature Immunology
  35. Exploiting innate immunity for cancer immunotherapy
    Ming Yi, Tianye Li, Mengke Niu, Qi Mei, Bin Zhao, Qian Chu, Zhijun Dai, Kongming Wu · 2023 · Molecular Cancer
  36. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
    Luca Cassetta, Espen S. Bækkevold, Sven Brandau, Anna Bujko, Marco Antonio Cassatella, Anca Dorhoi, Carsten Krieg, Ang Lin, Karin Loré, Olivia Marini et al. · 2019 · Cancer Immunology Immunotherapy
  37. Myeloid-Derived Suppressor Cells in Sepsis
    Irene T. Schrijver, Charlotte Théroude, Thierry Roger · 2019 · Frontiers in Immunology
  38. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
    Schneider, Kai Markus, Mohs, Antje, Gui, Wenfang, Galvez, Eric J. C., Candels, Lena Susanna, Hoenicke, Lisa, Muthukumarasamy, Uthayakumar, Holland, Christian H., Elfers, Carsten, Kilic, Konrad et al. · 2022 · Nature Communications
  39. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
    Yumei He, Xing Li, Michela Perego, Yulia Nefedova, Andrew V. Kossenkov, Erik A. Jensen, Valerian E. Kagan, Yufeng Liu, Shuyu Fu, Qing‐Jian Ye et al. · 2018 · Nature Medicine
  40. Myeloid cell-targeted therapies for solid tumours
    Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, Padmanee Sharma · 2022 · Nature reviews. Immunology
  41. Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
    Paula Michea, Floriane Noël, Ève Zakine, Urszula Czerwińska, Philémon Sirven, Omar Abouzid, Christel Goudot, Alix Scholer‐Dahirel, Anne Vincent‐Salomon, Fabien Reyal et al. · 2018 · Nature Immunology
  42. Unique pattern of neutrophil migration and function during tumor progression
    Sima Patel, Shuyu Fu, Jérôme Mastio, George A. Dominguez, Abhilasha Purohit, Andrew V. Kossenkov, Cindy Lin, Kevin M. Alicea-Torres, Mohit Sehgal, Yulia Nefedova et al. · 2018 · Nature Immunology
  43. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Liyang Fei, Xiaochen Ren, Haijia Yu, Yifan Zhan · 2021 · Frontiers in Immunology
  44. Mechanisms of immune evasion in bladder cancer
    Paul L. Crispen, Sergei A. Kusmartsev · 2019 · Cancer Immunology Immunotherapy
  45. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
    Baohua Li, Malgorzata Anna Garstka, Zongfang Li · 2019 · Molecular Immunology
  46. Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function
    Merav E. Shaul, Zvi Gregorio Fridlender · 2018 · FEBS Journal
  47. Myeloid suppressor cells in cancer and autoimmunity
    Sica, Antonio, Massarotti, Marco · 2017 · Journal of Autoimmunity
  48. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
    Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, Benedikt Höing, Oliver Kanaan, Nina Dominas, Timon Hussain, Freya Droege, Christian Eyth, Boris Alexander Hadaschik et al. · 2018 · Clinical Cancer Research
  49. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
    Antonino Bruno, Lorenzo Mortara, Denisa Baci, Douglas McClain Noonan, Adriana Albini · 2019 · Frontiers in Immunology
  50. The role of neutrophils in host defense and disease
    Heather K. Lehman, Brahm H. Segal · 2020 · Journal of Allergy and Clinical Immunology
  51. Gemtuzumab ozogamicin in acute myeloid leukemia
    Colin D. Godwin, Robert Peter Gale, Roland B. Walter · 2017 · Leukemia
  52. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils
    Michela Perego, Vladimir A. Tyurin, Yulia Y. Tyurina, Jonathan Yellets, Timothy Nacarelli, Cindy Lin, Yulia Nefedova, Andrew V. Kossenkov, Qin Liu, Sreesha Sreedhar et al. · 2020 · Science Translational Medicine
  53. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
    Matthew Dysthe, Robin Parihar · 2020 · Advances in experimental medicine and biology
  54. Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity
    Louise Elliott, Glen A. Doherty, Kieran D. Sheahan, Elizabeth J. Ryan · 2017 · Frontiers in Immunology
  55. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
    Richard P. Tobin, Kimberly Rae Jordan, William Allen Robinson, Dana M. Davis, Virginia F. Borges, Rene C. Gonzalez, Karl D. Lewis, Martin D. McCarter · 2018 · International Immunopharmacology
  56. Innate immune cells in cirrhosis
    Christine Bernsmeier, Van der Merwe, Axel Périanin · 2020 · Journal of Hepatology
  57. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
    Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczyńska-Moncznik, Oktawia Osiecka, Xiaoying Hu, Ida Marie Rundgren, Ang Lin, Kim C. M. Santegoets, Utku Horzum, Ana Godinho‐Santos et al. · 2020 · Journal for ImmunoTherapy of Cancer
  58. The link between immunity, autoimmunity and endometriosis: a literature update
    Zhang, Tao, De Carolis, Caterina, Man, Gene Chi Wai, Wang, Chi Chiu · 2018 · Autoimmunity Reviews
  59. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
    Jingying Zhou, Man Liu, Hanyong Sun, Yu Feng, Liangliang Xu, Anthony W.H. Chan, JOANNA H.M. TONG, John Wong, Charing C. N. Chong, Paul B.S. Lai et al. · 2017 · Gut
  60. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
    Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, Kristi Marquardt, Reza Beheshti Zavareh, Luke L. Lairson, Michael B. A. Oldstone, Judith A. Varner, Livia T. Hegerova, Qing Cao et al. · 2024 · Science
  61. Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression
    Song, Guohe, Shi, Yang, Zhang, Meiying, Goswami, Shyamal, Afridi, Saifullah, Meng, Lu, Ma, Jiaqiang, Chen, Yi, Lin, Youpei, Zhang, Juan et al. · 2020 · Cell Discovery
  62. Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
    Tyler Joseph Alban, Alvaro G. Alvarado, Mia Dahl Sørensen, Defne Bayık, Josephine Volovetz, Emily Serbinowski, Erin E. Mulkearns-Hubert, Maksim Sinyuk, James S. Hale, Giovana R. Onzi et al. · 2018 · JCI Insight
  63. Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’
    George C. Prendergast, Arpita Mondal, Souvik Dey, Lisa D. Laury‐Kleintop, Alexander J. Muller · 2017 · Trends in cancer
  64. Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
    Zhengyi Wang, Xiaoying Wu · 2020 · Cancer Medicine
  65. Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer
    Subir Biswas, Gunjan Mandal, Sougata Roy Chowdhury, Suman Purohit, Kyle K. Payne, Carmen M. Anadon, Arnab Gupta, Patricia Swanson, Xiaoqing Yu, Jose Ramon Conejo-Garcia et al. · 2019 · The Journal of Immunology
  66. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
    Athalia Rachel Pyzer, Dina Stroopinsky, Hasan N. Rajabi, Abigail J. Washington, Ashujit Tagde, Maxwell Douglas Coll, Jacqueline Fung, Mary Paty Bryant, Leandra Cole, Kristen Anna Palmer et al. · 2017 · Blood
  67. Radiation, inflammation and the immune response in cancer
    Kelly J. McKelvey, Amanda L. Hudson, Michael Back, Tom Eade, Connie Irene Diakos · 2018 · Mammalian Genome
  68. Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer
    Arsela Prelaj, Rebecca Yin Tay, Roberto Ferrara, Nathalie Chaput, Benjamin Besse, Raffaele Califano · 2018 · European Journal of Cancer
  69. Cellular Innate Immunity: An Old Game with New Players
    Georg Gasteiger, Andrea D’Osualdo, David A. Schubert, Alexander N.R. Weber, Emanuela M. Bruscia, Dominik Hartl · 2016 · Journal of Innate Immunity
  70. Myeloid-derived suppressor cells—new and exciting players in lung cancer
    Zhenzhen Yang, Jiacheng Guo, Lanling Weng, Wenxue Tang, Shuiling Jin, Wang Ma · 2020 · Journal of Hematology & Oncology
  71. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
    Julia Kargl, Xiaodong Zhu, Huajia Zhang, Grace H. Y. Yang, Travis J. Friesen, Melissa Shipley, Dean Y. Maeda, John A. Zebala, Jill McKay-Fleisch, Gavin D. Meredith et al. · 2019 · JCI Insight
  72. Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody
    Dominguez, George A., Condamine, Thomas, Mony, Sridevi, Hashimoto, Ayumi, Wang, Fang, Liu, Qin, Forero, Andres, Bendell, Johanna, Witt, Robert, Hockstein, Neil et al. · 2017 · Clinical Cancer Research
  73. Myeloid‐Derived Suppressor Cell Membrane‐Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death
    Guang‐Tao Yu, Lang Rao, Hao Wu, Leilei Yang, Lin‐Lin Bu, Wei‐Wei Deng, Lei Wu, Xiaolin Nan, Wen‐Feng Zhang, Xingzhong Zhao et al. · 2018 · Advanced Functional Materials
  74. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
    Rosalinda Trovato, Alessandra Fiore, Sara Sartori, Stefania Canè, Rosalba Giugno, Luciano Cascione, Salvatore Paiella, Roberto Salvia, Francesco De Sanctis, Ornella Poffe et al. · 2019 · Journal for ImmunoTherapy of Cancer
  75. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
    Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M. Teresa Ciudad, Andreas Kloetgen, Bethany L. MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago da Silva Medina, Stefano Ugel et al. · 2019 · Science Immunology
  76. Trial watch: IDO inhibitors in cancer therapy
    Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Erika Vacchelli · 2020 · OncoImmunology
  77. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
    Farhad Jadidi-Niaragh, F. Atyabi, A. Rastegari, N. Kheshtchin, S. Arab, Hadi Hassannia, M. Ajami, Zahra Mirsanei, S. Habibi, F. Masoumi et al. · 2017 · Journal of Controlled Release
  78. Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters
    Gábor J. Szebeni, Csaba Vízler, Klára Kitajka, László Géza Puskás · 2017 · Mediators of Inflammation
  79. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells
    Kaipeng Jin, Chao Qian, Jinti Lin, Bing Liu · 2023 · Frontiers in Oncology
  80. Immune cell subset differentiation and tissue inflammation
    Pu Fang, Xinyuan Li, Jin Dai, Lauren E. Cole, Javier Andres Camacho, Yuling Zhang, Yong Hua Ji, Jingfeng Wang, Xiaofeng Yang, Hong Wang · 2018 · Journal of Hematology & Oncology
  81. Hypoxia-inducible factors and innate immunity in liver cancer
    Vincent Wai‐Hin Yuen, Carmen Chak‐Lui Wong · 2020 · Journal of Clinical Investigation
  82. Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
    Xuezhen Zeng, Guanrui Liao, Shumin Li, Haining Liu, Xiao Hui Zhao, Shuang Li, Kai Lei, Shenghua Zhu, Zhihang Chen, Yi Zhao et al. · 2022 · Hepatology
  83. CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions
    C Blattner, Viktor Fleming, Rebekka Weber, Bianca S. Himmelhan, Peter Altevogt, Christoffer Gebhardt, Torsten J. Schulze, Hila Razon, Elias Hawila, Gizi Wildbaum et al. · 2018 · Cancer Research
  84. CD300ld on neutrophils is required for tumour-driven immune suppression
    Chaoxiong Wang, Xichen Zheng, Jinlan Zhang, Xiaoyi Jiang, Jia Wang, Yuwei Li, Xiaonan Li, Guanghui Shen, Jiayin Peng, P Zheng et al. · 2023 · Nature
  85. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
    Zhao, Yue, Shuen, Timothy Wai Ho, Toh, Tan Boon, Chan, Xue Ying, Liu, Min, Tan, Sue Yee, Fan, Yong, Yang, Hechuan, Lyer, Shridhar Ganpathi, Bonney, Glenn Kunnath et al. · 2018 · Gut
  86. Tumor immune microenvironment in head and neck cancers
    Samantha M. Y. Chen, Alexandra L. Krinsky, Rachel A. Woolaver, Xiaoguang Wang, Zhangguo Chen, Jing Hong Wang · 2020 · Molecular Carcinogenesis
  87. Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer
    T. Kwak, Fang Wang, Hui Deng, T. Condamine, Vinit Kumar, Michela Perego, A. Kossenkov, L. Montaner, Xiao-Wei Xu, Wei Xu et al. · 2020 · Cell Reports
  88. STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
    Berger, Gilles, Knelson, Erik H., Jimenez-Macias, Jorge L., Nowicki, Michal O., Han, Saemi, Panagioti, Eleni, Lizotte, Patrick H., Adu-Berchie, Kwasi, Stafford, Alexander, Dimitrakakis, Nikolaos et al. · 2022 · Proceedings of the National Academy of Sciences
  89. Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
    Nicolò Bancaro, Bianca Calì, Martina Troiani, Angela Rita Elia, Rydell Alvarez Arzola, Giuseppe Attanasio, Ping Lai, Mateus Crespo, Bora Gürel, Rita Pereira et al. · 2023 · Cancer Cell
  90. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
    Junli Lu, Yiming Luo, Dean Rao, Tiantian Wang, Zhen Lei, Xiaoping Chen, Bixiang Zhang, Yiwei Li, Bi‐Feng Liu, Limin Xia et al. · 2024 · Experimental Hematology and Oncology
  91. Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis
    Elham Safarzadeh, Mona Orangi, Hamed Mohammadi, Farhad Babaie, Behzad Baradaran · 2017 · Journal of Cellular Physiology
  92. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
    Man Liu, Jingying Zhou, Xiaoyu Liu, Yu Feng, Weiqin Yang, Feng Wu, Otto Ka-Wing Cheung, Hanyong Sun, Xuezhen Zeng, Wenshu Tang et al. · 2019 · Gut
  93. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
    Maohua Huang, Yuning Lin, Chenran Wang, Lijuan Deng, Minfeng Chen, Yehuda G. Assaraf, Zhe‐Sheng Chen, Wen‐Cai Ye, Dongmei Zhang · 2022 · Drug Resistance Updates
  94. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
    Rei Mizuno, Kenji Kawada, Yoshiharu Sakai · 2019 · International Journal of Molecular Sciences
  95. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
    Zhiyong Wang, Victoria H. Wu, Michael M. Allevato, Mara Gilardi, Yudou He, Juan Luis Callejas‐Valera, Lynn A. Vitale-Cross, Daniel Martı́n, Panomwat Amornphimoltham, James Mcdermott et al. · 2019 · Nature Communications
  96. Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway
    Lai, Ping, Liu, Lei, Bancaro, Nicolò, Troiani, Martina, Calì, Bianca, Li, Yuxin, Chen, Jingjing, Singh, Prafull Kumar, Arzola, Rydell Alvarez, Attanasio, Giuseppe et al. · 2025 · Immunity
  97. Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
    Marco Bezzi, Nina Seitzer, Tomoki Ishikawa, Markus Reschke, Ming Chen, Guocan Wang, Caitlin Mitchell, Christopher Ng, Jesse Mae Katon, Andrea Lunardi et al. · 2018 · Nature Medicine
  98. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
    Sushil Kumar, David W. Wilkes, Nina Samuel, Mario Andres Blanco, Anupma Nayak, Kevin M. Alicea-Torres, Christian B. Gluck, Satrajit Sinha, Dmitry I. Gabrilovich, Rumela Chakrabarti · 2018 · Journal of Clinical Investigation
  99. Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
    Chenghui Yang, Zhen Wang, Lili Li, Zhigang Zhang, Xiaoyan Jin, Pin Wu, Shanshan Sun, Jun Pan, Ke Su, Fang Jia et al. · 2021 · Journal for ImmunoTherapy of Cancer
  100. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
    Jung, Keehoon, Heishi, Takahiro, Khan, Omar F., Kowalski, Piotr S., Incio, Joao, Rahbari, Nuh N., Chung, Euiheon, Clark, Jeffrey W., Willett, Christopher G., Luster, Andrew D. et al. · 2017 · Journal of Clinical Investigation